nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AAV2 and severe acute hepatitis of unknown aetiology
|
The Lancet Gastroenterology & Hepatology, |
|
|
8 |
6 |
p. 493 |
artikel |
2 |
Are postbiotics key to the potential benefits of fermented foods?
|
Gill, Paul |
|
|
8 |
6 |
p. 509 |
artikel |
3 |
Breaking the bathroom stigma on Channel 4
|
Becker, Stephanie C |
|
|
8 |
6 |
p. 510 |
artikel |
4 |
Correction to Lancet Gastroenterol Hepatol 2022; 7: 522–32
|
|
|
|
8 |
6 |
p. e5 |
artikel |
5 |
Effect of the COVID-19 pandemic on endoscopic surveillance in Lynch syndrome in the Netherlands
|
van Liere, Elsa L S A |
|
|
8 |
6 |
p. 504-506 |
artikel |
6 |
Equality, diversity, and inclusion in UK gastroenterology
|
Veitch, Andrew |
|
|
8 |
6 |
p. 504 |
artikel |
7 |
Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis
|
Li, Yunhao |
|
|
8 |
6 |
p. 553-564 |
artikel |
8 |
How do global trends in Helicobacter pylori prevalence inform prevention planning?
|
Butt, Julia |
|
|
8 |
6 |
p. 498-499 |
artikel |
9 |
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis
|
Artenie, Adelina |
|
|
8 |
6 |
p. 533-552 |
artikel |
10 |
Inflammation and malnutrition in inflammatory bowel disease
|
Massironi, Sara |
|
|
8 |
6 |
p. 579-590 |
artikel |
11 |
Outcomes of minimum unit pricing for alcohol in Scotland
|
The Lancet Gastroenterology & Hepatology, |
|
|
8 |
6 |
p. 493 |
artikel |
12 |
Research in Brief
|
Baker, Holly |
|
|
8 |
6 |
p. 508 |
artikel |
13 |
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial
|
Israelsen, Mads |
|
|
8 |
6 |
p. 523-532 |
artikel |
14 |
Rifaximin-α in alcohol-associated liver disease
|
Xie, Chencheng |
|
|
8 |
6 |
p. 495-497 |
artikel |
15 |
Semaglutide in NASH-related cirrhosis: too late to the party?
|
Bril, Fernando |
|
|
8 |
6 |
p. 494-495 |
artikel |
16 |
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial
|
Loomba, Rohit |
|
|
8 |
6 |
p. 511-522 |
artikel |
17 |
Status of HBV birth dose vaccination in Africa: the impact of COVID-19 and Gavi support on policy development
|
Njuguna, Henry N |
|
|
8 |
6 |
p. 502-503 |
artikel |
18 |
The intersection between eating disorders and gastrointestinal disorders: a narrative review and practical guide
|
Staller, Kyle |
|
|
8 |
6 |
p. 565-578 |
artikel |
19 |
The road to HIV and HCV elimination among people who inject drugs
|
Corona-Mata, Diana |
|
|
8 |
6 |
p. 497-498 |
artikel |
20 |
Top 10 research priorities for irritable bowel syndrome: results of a James Lind Alliance priority setting partnership
|
Black, Christopher J |
|
|
8 |
6 |
p. 499-501 |
artikel |
21 |
US Government plans overhaul of organ transplantation system
|
Furlow, Bryant |
|
|
8 |
6 |
p. 507 |
artikel |